The healthcare automation firm projects non-GAAP EPS of $2.15-$2.30 for 2026 while widening product bookings to $425M-$560M.
Omnicell updated its 2026 financial outlook, projecting non-GAAP earnings per share between $2.15 and $2.30. The company also widened its product bookings range to $425 million-$560 million, reflecting stronger demand expectations.
Second-quarter revenue reached $312 million, aligning with or exceeding internal forecasts. Profitability outperformed prior guidance, driven by solid execution across key metrics, according to management.
The revised outlook follows a quarter where results met or surpassed expectations, reinforcing confidence in the company’s growth trajectory.